Home › Funds › EcoR1 Capital, LLC › ETON
EcoR1 Capital, LLC position in ETON
ETON PHARMACEUTICALS INC COM · Health Care
EcoR1 Capital, LLC reported holding 2,171,938 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$78.6M, representing 4.04% of its reported portfolio and ranking #4 among its reported holdings. EcoR1 Capital, LLC has disclosed ETON holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's ETON position evolved
EcoR1 Capital, LLC first disclosed a stake in ETON in Q3 2024 at 228,000 shares (US$1.4M). The position peaked in Q2 2026 at 2,171,938 shares, worth US$78.6M. Across 8 filings, EcoR1 Capital, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,171,938 shares valued at US$78.6M. Notable position changes include a 34% trim in Q4 2024 (shares fell 3% over the following quarter), a 67% trim in Q1 2025 (shares rose 10% over the following quarter), a 3921% increase in Q2 2025 (shares rose 52% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 228.00K | $1.37M | New |
| Q4 2024 | 151.40K | $2.02M | Reduce |
| Q1 2025 | 50.50K | $655.49K | Reduce |
| Q2 2025 | 2.03M | $28.94M | Add |
| Q3 2025 | 2.03M | $44.12M | Hold |
| Q4 2025 | 2.03M | $34.34M | Hold |
| Q1 2026 | 2.17M | $53.60M | Add |
| Q2 2026 | 2.17M | $78.62M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$42.6M), National Philanthropic Trust (US$17.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 1.18M sh · $42.57M · Q2 2026
- National Philanthropic Trust 492.11K sh · $17.81M · Q2 2026
- Westside Investment Management, Inc. 431.16K sh · $15.61M · Q2 2026
- Pillsbury Lake Capital LLC 387.16K sh · $14.02M · Q2 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Lumbard & Kellner, LLC 175.91K sh · $6.37M · Q2 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- Aristides Capital LLC 145.41K sh · $5.26M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 137.57K sh · $4.98M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held ETON?
EcoR1 Capital, LLC has disclosed ETON holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is EcoR1 Capital, LLC's current position in ETON?
As of Q2 2026, EcoR1 Capital, LLC holds 2.17M shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $78.62M, representing 4.04% of its reported portfolio and ranking #4.
Has EcoR1 Capital, LLC been buying or selling ETON?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in ETON. The position peaked in Q2 2026 at 2.17M shares.
Which other funds hold ETON?
Other major institutional holders of ETON include Opaleye Management Inc., Nantahala Capital Management, LLC, National Philanthropic Trust, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.